Registered entities
Checkmate Pharmaceuticals, Inc.
Reg. No. 5755208United States
Innovation
7 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 2,089 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 1 |
Investor mix
11 investors on record; lead investors include Decheng Capital, F-Prime Capital, Longitude Capital, Novo Holdings; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 73% |
| Private equity | 1 | 9% |
| Other / undisclosed | 2 | 18% |